Merck mulls selling off veterinary products, its own or Schering-Plough’s, before $41B merger

WHITEHOUSE STATION, N.J. — Drugmaker Merck & Co. is considering selling some of its veterinary medicine assets or the animal health business of Schering-Plough Corp., as it prepares to acquire its New Jersey neighbor.